Evidence map›Paper›PMID 20808146›Full record

Trial reportThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2011

Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram.

Eric J Lenze, Rose C Mantella, Peichang Shi, Alison M Goate, Petra Nowotny, Meryl A Butters, Carmen Andreescu, Paul A Thompson, Bruce L Rollman

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Use of Salivary Diurnal Cortisol as an Outcome Measure in Randomised Controlled Trials: a Systematic Review.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2016
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Emotion reactivity and regulation in late-life generalized anxiety disorder: functional connectivity at baseline and post-treatment.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2015
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Generalized anxiety disorder, psychiatric comorbidities, and suicide.Social psychiatry and psychiatric epidemiology · 2026
    Article
  12. Review
  13. Review
  14. Review
  15. Attachment orientation and platelet activity.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Eric J LenzeDepartment of Psychiatry, Washington University School of Medicine, St Louis, MO 63110, USA. lenzee@wustl.edu
Rose C Mantella
Peichang Shi
Alison M Goate
Petra Nowotny
Meryl A Butters
Carmen Andreescu
Paul A Thompson
Bruce L Rollman
Washington University in St. Louis · USUniversity of Pittsburgh · USAbbott Fund · USUniversity of South Dakota · US

Funding

OPERATIONS CORE (285-351)P30MH068579 · NIMH · WASHINGTON UNIVERSITY · PI MCMILLEN, J. CURTIS · 2004 to 2008
$7.0M
Research Network Development Core (pages 329-374)P30MH071944 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REYNOLDS, CHARLES F. · 2005 to 2009
$6.7M
Pharmacotherapy of Latelife Generalized Anxiety DisorderR01MH070547 · NIMH · WASHINGTON UNIVERSITY · PI LENZE, ERIC J · 2005 to 2009
$1.3M
NIMH NIH HHS P30 MH068579NIMH NIH HHS P30 MH071944NIMH NIH HHS P30 MH71944NIMH NIH HHS R01 MH070547
6 · The paper itself

Abstract

backgroundGeneralized anxiety disorder (GAD) is a common disorder in older adults, which has been linked to hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in this age group. The authors examined whether treatment of GAD in older adults with a selective serotonin reuptake inhibitor (SSRI) corrects this HPA axis hyperactivity.

methodsThe authors examined adults aged 60 years and older with GAD in a 12-week randomized controlled trial comparing the SSRI escitalopram with placebo. The authors collected salivary cortisol at six daily time points for 2 consecutive days to assess peak and total (area under the curve) cortisol, both at baseline and posttreatment.

resultsCompared with placebo-treated patients, SSRI-treated patients had a significantly greater reduction in both peak and total cortisol. This reduction in cortisol was limited to patients with elevated (above the median) baseline cortisol, in whom SSRI-treated patients showed substantially greater reduction in cortisol than did placebo-treated patients. Reductions in cortisol were associated with improvements in anxiety. Additionally, genetic variability at the serotonin transporter promoter predicted cortisol changes.

conclusionsSSRI treatment of GAD in older adults reduces HPA axis hyperactivity. Further research should determine whether these treatment-attributable changes are sustained and beneficial.

Indexed as

AgedAged, 80 and overAnxiety DisordersCitalopramFemaleGenotypeHumansHydrocortisoneHypothalamo-Hypophyseal SystemMaleMiddle AgedPituitary-Adrenal SystemPolymorphism, Single NucleotidePromoter Regions, GeneticSalivaSelective Serotonin Reuptake InhibitorsCitalopramHydrocortisoneSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, human

Identifiers

PMID20808146
PMCPMC3424606
OpenAlexW2165249749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.